Cargando…

Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells

BACKGROUND: Several signal transduction pathways have been reported being involved in the acquisition of P-glycoprotein (P-gp) mediated multi-drug resistance (MDR) upon exposure to anti-cancer drugs, whereas there is evidence indicating that the expression and activity of P-gp were not equally or ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Feifei, Wang, Fengliang, Yang, Ting, Sheng, Yuan, Zhong, Ting, Chen, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279688/ https://www.ncbi.nlm.nih.gov/pubmed/25550688 http://dx.doi.org/10.1186/s12935-014-0142-4

Ejemplares similares

Knockdown of PLC-gamma-2 and calmodulin 1 genes sensitizes human cervical adenocarcinoma cells to doxorubicin and paclitaxel
por: Stanislaus, Anthony, et al.
Publicado: (2012)

Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?
por: Zhang, Xudong, et al.
Publicado: (2018)

Sulbactam-enhanced cytotoxicity of doxorubicin in breast cancer cells
por: Wen, Shao-hsuan, et al.
Publicado: (2018)

Effects of suberoylanilide hydroxamic acid (SAHA) combined with paclitaxel (PTX) on paclitaxel-resistant ovarian cancer cells and insights into the underlying mechanisms
por: Liu, Zhaohui, et al.
Publicado: (2014)

TBX15/miR-152/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination
por: Jiang, Cheng-Fei, et al.
Publicado: (2021)

Modulation of doxorubicin-induced expression of the multidrug resistance gene in breast cancer cells by diltiazem and protection against cardiotoxicity in experimental animals
por: Al-malky, Hamdan S., et al.
Publicado: (2019)

Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line
por: Osman, Abdel-Moneim M, et al.
Publicado: (2012)

Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line
por: Li, Jie, et al.
Publicado: (2001)

Circ_0001721 enhances doxorubicin resistance and promotes tumorigenesis in osteosarcoma through miR-758/TCF4 axis
por: Guan, Huapeng, et al.
Publicado: (2021)

Combination treatment with hENT1 and miR-143 reverses gemcitabine resistance in triple-negative breast cancer
por: Xi, Yue, et al.
Publicado: (2022)

NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma
por: Le, Yong, et al.
Publicado: (2019)

Synergistic effect of paclitaxel and epigenetic agent phenethyl isothiocyanate on growth inhibition, cell cycle arrest and apoptosis in breast cancer cells
por: Liu, Katherine, et al.
Publicado: (2013)

Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer
por: Chen, Jihui, et al.
Publicado: (2021)

Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p
por: Liu, Jianhui, et al.
Publicado: (2021)

Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animals
por: Osman, Abdel-Moneim M, et al.
Publicado: (2013)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
por: Wang, Ling, et al.
Publicado: (2018)

β-Asarone increases doxorubicin sensitivity by suppressing NF-κB signaling and abolishes doxorubicin-induced enrichment of stem-like population by destabilizing Bmi1
por: Lv, Li-Na, et al.
Publicado: (2019)

DNA methyltransferase 1 inhibits microRNA-497 and elevates GPRC5A expression to promote chemotherapy resistance and metastasis in breast cancer
por: Liu, Yaobang, et al.
Publicado: (2022)

A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells
por: Duan, Zhenfeng, et al.
Publicado: (2014)

3D collagen type I matrix inhibits the antimigratory effect of doxorubicin
por: Millerot-Serrurot, Emilie, et al.
Publicado: (2010)

Circ_ZFR contributes to the paclitaxel resistance and progression of non-small cell lung cancer by upregulating KPNA4 through sponging miR-195-5p
por: Li, Junmin, et al.
Publicado: (2021)

Combating drug resistance in acute myeloid leukaemia by drug rotations: the effects of quizartinib and pexidartinib
por: Yang, Jingmei, et al.
Publicado: (2021)

Effect of Gallic acid in potentiating chemotherapeutic effect of Paclitaxel in HeLa cervical cancer cells
por: Aborehab, Nora M., et al.
Publicado: (2019)

Synergistic effects of isomorellin and forbesione with doxorubicin on apoptosis induction in human cholangiocarcinoma cell lines
por: Hahnvajanawong, Chariya, et al.
Publicado: (2014)

Circular RNA circCSPP1 knockdown attenuates doxorubicin resistance and suppresses tumor progression of colorectal cancer via miR-944/FZD7 axis
por: Xi, Lanlan, et al.
Publicado: (2021)

HMGB1 mediates lipopolysaccharide-induced inflammation via interacting with GPX4 in colon cancer cells
por: Yang, Yuhan, et al.
Publicado: (2020)

Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer
por: Rajappa, Senthil, et al.
Publicado: (2018)

Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells
por: Yang, Q, et al.
Publicado: (2014)

BuFeiXiaoJiYin ameliorates the NLRP3 inflammation response and gut microbiota in mice with lung cancer companied with Qi-yin deficiency
por: Jiang, Rui-yuan, et al.
Publicado: (2022)

HE4 overexpression decreases pancreatic cancer Capan-1 cell sensitivity to paclitaxel via cell cycle regulation
por: Guo, Fengbiao, et al.
Publicado: (2020)

PTOP and TRF1 help enhance the radio resistance in breast cancer cell
por: Li, Zheng, et al.
Publicado: (2014)

RNF181 modulates Hippo signaling and triple negative breast cancer progression
por: Zhou, Rui, et al.
Publicado: (2020)

Long non-coding RNA SNHG6 regulates the sensitivity of prostate cancer cells to paclitaxel by sponging miR-186
por: Cao, Chunhui, et al.
Publicado: (2020)

Carbonic anhydrase 12 gene silencing reverses the sensitivity of paclitaxel in drug-resistant breast cancer cells
por: Huang, Ting, et al.
Publicado: (2021)

Telehealth intervention for Latina breast cancer survivors: A pilot
por: Meneses, Karen, et al.
Publicado: (2018)

Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screening
por: Woof, Victoria G, et al.
Publicado: (2021)

Changes in DNA methylation are associated with the development of drug resistance in cervical cancer cells
por: Chen, Chih-Cheng, et al.
Publicado: (2015)

Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer
por: Huang, Dabing, et al.
Publicado: (2018)

Cisplatin loaded multiwalled carbon nanotubes reverse drug resistance in NSCLC by inhibiting EMT
por: Qi, Yuxin, et al.
Publicado: (2021)

Comparison of characteristics in Mexican women with breast cancer according to healthcare coverage
por: Martinez-Cannon, Bertha Alejandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qvqiqfspmt0e2e1fjkg2oqt8ag